| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380582A1 FSH mimetics for the treatment of infertility |
| 01/14/2004 | EP1380291A1 PDE IV inhibitors for treating multiple sclerosis |
| 01/14/2004 | EP1380290A1 Cross-beta structure pathway and its therapeutic relevance |
| 01/14/2004 | EP1379882A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders |
| 01/14/2004 | EP1379879A2 Diagnosis and treatment of alzheimer's disease |
| 01/14/2004 | EP1379873A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379688A2 Polymorphisms in the human cmoat gene and uses thereof |
| 01/14/2004 | EP1379678A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/14/2004 | EP1379677A2 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379665A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379661A2 Regulation of human gnat acetyltransferase-like protein |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379655A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379647A2 Mammalian cytokines; receptors; related reagents and methods |
| 01/14/2004 | EP1379636A2 Human neprilysin protease |
| 01/14/2004 | EP1379635A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379555A2 Modified interferon alpha with reduced immunogenicity |
| 01/14/2004 | EP1379554A2 Proteins, polynucleotides encoding them and methods of using the same |
| 01/14/2004 | EP1379551A2 Adp-ribosylating bacterial toxins |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379548A2 Novel rgs9 protein binding interactions and methods of use thereof |
| 01/14/2004 | EP1379547A2 Pro-drug and use thereof as a medicament |
| 01/14/2004 | EP1379546A2 Peptide for the diagnosis and therapy of alzheimer's disease |
| 01/14/2004 | EP1379543A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/14/2004 | EP1379540A2 Polynucleotides and polypeptides associated with the nf-kb pathway |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379529A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity |
| 01/14/2004 | EP1379515A1 Lipid lowering biphenylcarboxamides |
| 01/14/2004 | EP1379337A1 Generation of pharmaceutical agent particles using focused acoustic energy |
| 01/14/2004 | EP1379283A2 Identification of target-specific folding sites in peptides and proteins |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379278A2 Method of inducing proliferation of retinal stem cells |
| 01/14/2004 | EP1379276A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379271A1 Method for treating von willebrand's disease |
| 01/14/2004 | EP1379270A1 Method of inducing immune tolerance |
| 01/14/2004 | EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 01/14/2004 | EP1379268A1 Chondrogenic potential of human bone marrow-derived cd105?+ cells by bmp |
| 01/14/2004 | EP1379267A1 The use of the protein uk114 for the treatment and the prevention of chronic active hepatitis |
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379264A1 Human secreted proteins |
| 01/14/2004 | EP1379263A2 Mutated mhc molecules for use in immune suppression |
| 01/14/2004 | EP1379224A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/14/2004 | EP1379221A2 Pharmaceutical product with reticulated crystalline microstructure |
| 01/14/2004 | EP1379139A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 01/14/2004 | EP1379134A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 01/14/2004 | EP1379133A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 01/14/2004 | EP1379132A2 Human secreted proteins |
| 01/14/2004 | EP1379131A1 Regulation of weight |
| 01/14/2004 | EP1014989B1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 01/14/2004 | EP0975761B1 Recombinant human beta interferon with enhanced solubility |
| 01/14/2004 | EP0942758B1 Compounds with improved inductive effect on cartilage and bones |
| 01/14/2004 | EP0939644B1 Enhanced stimulation of erythropoiesis |
| 01/14/2004 | EP0832229B1 Cd40l mutein |
| 01/14/2004 | EP0816381B1 Polyethylene glycol modified hepatocyte growth factor (hgf) |
| 01/14/2004 | EP0758227B1 Modulated release from biocompatible polymers |
| 01/14/2004 | EP0725795B1 Single-chain forms of the glycoprotein hormone quartet |
| 01/14/2004 | EP0690991B2 Novel anticoagulant cofactor activity |
| 01/14/2004 | EP0636174B1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides |
| 01/14/2004 | CN1468310A Method for constructing cell strain of expression mutation type human tissue plasmin activator and preparation method of expressing protein |
| 01/14/2004 | CN1468309A Anti-il-12 antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468303A Factor vii glycoforms |
| 01/14/2004 | CN1468302A Gsk3 polypeptides |
| 01/14/2004 | CN1468259A Immunotherapy for chronic myelocytic leukemia |
| 01/14/2004 | CN1468258A Glucagon-like peptide-1 analogs |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1468256A Purification of hbv antigens for use in vaccines |
| 01/14/2004 | CN1468144A Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/14/2004 | CN1468123A Method and composition for altering a b cell mediated pathology |
| 01/14/2004 | CN1468120A Electro-powder |
| 01/14/2004 | CN1468113A Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/14/2004 | CN1468109A 疫苗组合物 Vaccine composition |
| 01/14/2004 | CN1468108A Bone health compositions derived from milk |
| 01/14/2004 | CN1468095A Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 01/14/2004 | CN1468093A Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467291A Avian interleukin-2 (IL-2) gene and eukaryon expressing plasmid and immunity reinforcing agent of bird vaccine |
| 01/14/2004 | CN1467224A Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 01/14/2004 | CN1467222A Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line |
| 01/14/2004 | CN1467220A Tripeptide analog, preparing method, medicine composition containing the same and uses |
| 01/14/2004 | CN1467219A Pentapeptide analog, preparation and uses thereof |
| 01/14/2004 | CN1466996A Human SARS coronary virus receptor inhibitor |
| 01/14/2004 | CN1466995A Anti-consenescence capsule containing modification SOD |
| 01/14/2004 | CN1466994A Compositions and therapeutic use |